The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Open accessPublished version of a preprint
Abstract
A new and highly pathogenic coronavirus (severe acute respiratory syndrome coronavirus-2, SARS-CoV-2) caused an outbreak in Wuhan city, Hubei province, China, starting from December 2019 that quickly spread nationwide and to other countries around the world 1-3. Here, to better understand the initial step of infection at an atomic level, we determined the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 bound to the cell receptor ACE2. The overall ACE2-binding mode of the SARS-CoV-2 RBD is nearly identical to that of the SARS-CoV RBD, which also uses ACE2 as the cell receptor 4. Structural analysis identified residues in the SARS-CoV-2 RBD that are essential for ACE2 binding, the majority of which either are highly conserved or share similar side chain properties with those in the SARS-CoV RBD. Such similarity in structure and sequence strongly indicate convergent evolution between the SARS-CoV-2 and SARS-CoV RBDs for improved binding to ACE2, although SARS-CoV-2 does not cluster within SARS and SARS-related coronaviruses 1-3,5. The epitopes of two SARS-CoV antibodies that target the RBD are also analysed for binding to the SARS-CoV-2 RBD, providing insights into the future identification of cross-reactive antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This amino acid sequence extends from residue Thr333 to residue Gly526 [28].”
From Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells (2022) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Importantly, ACE2 (angiotensin-converting enzyme 2) had been identified as the receptor for SARS-CoV 4,5 and SARS-CoV-2.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [7]
In the citing paper
“When binding to hACE2, spike amino acid F486 interacts with hACE2 residues L79, M82 and Y83, which collectively comprise a hotspot for ACE2 differences between mammalian species13.”
From Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa (2022) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citation[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationPhaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Self-citationMartínez–González, M. B. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,292
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,961
Cited by
Sorted by citations
Items 501–600 of 1,026
The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury
Irrera, N., Russo, M., Pallio, G., Bitto, A., Mannino, F., Minutoli, L., Altavilla, D., & Squadrito, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176204 · Cited by 112
High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models
Li, W., Schäfer, A., Kulkarni, S. S., Liu, X., Martinez, D. R., Chen, C., Sun, Z., Leist, S. R., Drelich, A. K., Zhang, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.007 · Cited by 112
Self-citationNatural triterpenoids from licorice potently inhibit SARS-CoV-2 infection
Yang, Y., Li, J., Lai, X., Zhang, M., Kuang, Y., Bao, Y., Yu, R., Hong, W., Muturi, E., Xue, H., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.11.012 · Cited by 112
Binding of the SARS-CoV-2 spike protein to glycans
Hao, W., Ma, B., Li, Z., Wang, X., Gao, X., Li, Y., Qin, B., Shang, S., Cui, S., & Tan, Z. (2021) · 中国科学通报：英文版 · doi:10.1016/j.scib.2021.01.010 · Cited by 111
Self-citationNguyen, T. T., Pathirana, P. N., Nguyen, Q. V. H., Nguyen, Q. V. H., Bhatti, A., Nguyen, N. D., Nguyen, Q. V. H., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-83105-3 · Cited by 111
Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review
Caramaschi, S., Kapp, M., Miller, S., Eisenberg, R., Johnson, J. E., Epperly, G., Maiorana, A., Silvestri, G., & Giannico, G. A. (2021) · Modern Pathology · doi:10.1038/s41379-021-00814-w · Cited by 111
Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites
Qiao, B., & de la Cruz, M. O. (2020) · ACS Nano · doi:10.1021/acsnano.0c04798 · Cited by 110
Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies
Chen, J., Gao, K., Wang, R., & Wei, G. (2021) · Chemical Science · doi:10.1039/d1sc01203g · Cited by 110
Liu, X., Liang, W. P., Xu, F., Zhao, F., Huang, Y., Fan, Z., Mei, S., Hu, Y., Zhai, L., Guo, J., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abg8744 · Cited by 110
Glycosylation of viral proteins: Implication in virus–host interaction and virulence
Feng, T., Zhang, J., Chen, Z., Pan, W., Chen, Z., Yan, Y., & Dai, J. (2022) · Virulence · doi:10.1080/21505594.2022.2060464 · Cited by 110
Low-Cost Biosensor Technologies for Rapid Detection of COVID-19 and Future Pandemics
de Araujo, W. R., Lukas, H., Torres, M. D. T., Gao, W. F., & de la Fuente‐Núñez, C. (2024) · ACS Nano · doi:10.1021/acsnano.3c01629 · Cited by 110
Lam, S. D., Bordin, N., Waman, V., Scholes, H. M., Ashford, P., Sen, N., van Dorp, L., Rauer, C., Dawson, N. L., Pang, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71936-5 · Cited by 109
Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification
Li, X., Zhu, W., Fan, M., Zhang, J., Peng, Y., Huang, F., Wang, N., He, L., Zhang, L., Holmdahl, R., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.04.001 · Cited by 109
Self-citationPiplani, S., Singh, P. K., Winkler, D. A., & Petrovsky, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-92388-5 · Cited by 109
Tao, K., Tzou, P. L., Nouhin, J., Bonilla, H. F., Jagannathan, P., & Shafer, R. W. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-21 · Cited by 109
Murugan, N. A., Pandian, C. J., & Jeyakanthan, J. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1777901 · Cited by 108
Wang, G., Yang, M., Duan, Z., Liu, F., Jin, L., Long, C., Zhang, M., Tang, X., Xu, L., Li, Y.-C., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00450-0 · Cited by 108
The acid sphingomyelinase/ceramide system in COVID-19
Kornhuber, J., Hoertel, N., & Gulbins, E. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01309-5 · Cited by 108
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Chavda, V. P., Bezbaruah, R., Deka, K., Nongrang, L., & Kalita, T. (2022) · Vaccines · doi:10.3390/vaccines10111926 · Cited by 108
Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19
Arora, R., Goel, R., Kumar, S., Chhabra, M., Saxena, S., Manchanda, V., & Pumma, P. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2020.08.029 · Cited by 107
Singh, A., Steinkellner, G., Köchl, K., Gruber, K. F., & Gruber, C. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-83761-5 · Cited by 107
Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
Xie, Y., Karki, C. B., Du, D., Li, H., Wang, J., Sobitan, A., Teng, S., Tang, Q., & Li, L. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.591873 · Cited by 107
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
D’Onofrio, N., Scisciola, L., Sardu, C., Trotta, M. C., FEO, M. D., Maiello, C., Mascolo, P., Micco, F. D., Turriziani, F., Municinò, E., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01286-7 · Cited by 107
Tabrizi, M. A., Fernandéz‐Blázquez, J. P., Medina, D. M., & Acedo, P. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113729 · Cited by 107
Clemente‐Suárez, V. J., Beltrán-Velasco, A. I., Ramos‐Campo, D. J., Mielgo‐Ayuso, J., Nikolaidis, P. Τ., Belando‐Pedreño, N., & Tornero-Aguilera, J. F. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113667 · Cited by 107
Lipopolysaccharide delivery systems in innate immunity
Liu, J., Kang, R., & Tang, D. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.02.003 · Cited by 107
Khelfaoui, H., Harkati, D., & Saleh, B. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1803967 · Cited by 106
Hussain, M., Jabeen, N., Amanullah, A., Baig, A. A., Aziz, B., Shabbir, S., Raza, F., & Uddin, N. (2020) · AIMS Microbiology · doi:10.3934/microbiol.2020021 · Cited by 106
ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
Saponaro, F., Rutigliano, G., Sestito, S., Bandini, L., Storti, B., Bizzarri, R., & Zucchi, R. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.588618 · Cited by 106
The global epidemic of SARS‐CoV‐2 variants and their mutational immune escape
Tian, D., Sun, Y., Zhou, J., & Ye, Q. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27376 · Cited by 106
Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery
Xu, X., & Xia, T. (2023) · ACS Nanoscience Au · doi:10.1021/acsnanoscienceau.2c00062 · Cited by 106
Behl, T., Kaur, I., BUNGAU, S. G., Kumar, A., Uddin, M. S., Kumar, C., Pal, G., Sahil, Shrivastava, K., Zengin, G., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118075 · Cited by 105
Bojadzic, D., Alcazar, O., & Buchwald, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.600372 · Cited by 105
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection
Li, T., Cai, H., Yao, H., Zhou, B., Zhang, N., van Vlissingen, M. F., Kuiken, T., Han, W., GeurtsvanKessel, C. H., Gong, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24905-z · Cited by 105
Self-citationYosri, N., El‐Wahed, A. A. A., Ghonaim, R., Khattab, O. M., Sabry, A., Ibrahim, M. A. A., Moustafa, M., Guo, Z., Zou, X., Algethami, A. F. M., et al. (2021) · Foods · doi:10.3390/foods10081776 · Cited by 105
Behl, T., Kaur, I., Aleya, L., Sehgal, A., Singh, S., Sharma, N., Bhatia, S., Al‐Harrasi, A., & BUNGAU, S. G. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.152072 · Cited by 105
Protein nanopore reveals the renin–angiotensin system crosstalk with single-amino-acid resolution
Jiang, J., Li, M., Wu, X., Ying, Y., Han, H., & Long, Y. (2023) · Nature Chemistry · doi:10.1038/s41557-023-01139-8 · Cited by 105
Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2
Sun, S., Gu, H., Cao, L., Chen, Q., Ye, Q., Yang, G., Li, R.-T., Fan, H., Deng, Y.-Q., Song, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25903-x · Cited by 104
Self-citationPandolfi, L., Bozzinì, S., Frangipane, V., Percivalle, E., Luigi, A. D., Violatto, M. B., Lopez, G., Gabanti, E., Carsana, L., D’Amato, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663303 · Cited by 104
COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms
Ostaszewski, M., Niarakis, A., Mazein, A., Kuperstein, I., Phair, R. D., Resendiz, A. O., Singh, V., Aghamiri, S. S., Acencio, M. L., Glaab, E., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110387 · Cited by 104
Montiel, V., Lobysheva, I. I., Gérard, L., Vermeersch, M., Pérez-Morga, D. L., Castelein, T., Mesland, J.-B., Hantson, P. E., Collienne, C., Gruson, D., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103893 · Cited by 104
Pasquarelli-do-Nascimento, G., Braz-de-Melo, H. A., Faria, S. S., Santos, I. D. O., Kobinger, G., & Magalhães, K. G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00530 · Cited by 103
Artese, A., Svicher, V., Costa, G., Salpini, R., Maio, V. C. D., Alkhatib, M., Ambrosio, F. A., Santoro, M. M., Assaraf, Y. G., Alcaro, S., et al. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100721 · Cited by 103
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
Mudgal, R. K., Nehul, S., & Tomar, S. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1805992 · Cited by 103
On the Challenges for the Diagnosis of SARS-CoV-2 Based on a Review of Current Methodologies
Mattioli, I. A., Hassan, A., Oliveira, O. N., & Crespilho, F. N. (2020) · ACS Sensors · doi:10.1021/acssensors.0c01382 · Cited by 103
Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production
Zhao, X., Chen, H., & Wang, H. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.629873 · Cited by 103
Huang, J., Wen, J., Zhou, M., Ni, S., Le, W., Chen, G., Wei, L. C., Zeng, Y., Qi, D., Pan, M., et al. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c01061 · Cited by 103
Liu, Z., VanBlargan, L. A., Bloyet, L.-M., Rothlauf, P. W., Chen, R. E., Stumpf, S., Zhao, H., Errico, J. M., Theel, E. S., Liebeskind, M. J., et al. (2020) · doi:10.1101/2020.11.06.372037 · Cited by 135
Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
Sempowski, G. D., Saunders, K. O., Acharya, P., Wiehe, K. J., & Haynes, B. F. (2020) · Cell · doi:10.1016/j.cell.2020.05.041 · Cited by 102
Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin
Qian, Y., Lei, T., Patel, P. S., Lee, C. H., Monaghan-Nichols, P., Xin, H.-B., Qiu, J., & Fu, M. (2021) · Journal of Virology · doi:10.1128/jvi.01396-21 · Cited by 102
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
Zhang, C., Wang, Y., Zhu, Y., Liu, C., Gu, C., Xu, S., Wang, Y., Zhou, Y., Wang, Y., Han, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20465-w · Cited by 101
Robust SARS-CoV-2 Infection in Nasal Turbinate Despite Systemic Neutralizing Antibody
Zhou, D., Chan, J. F., Zhou, B., Zhou, R., Li, S., Shan, S., Liu, L., Zhang, J., Chen, S. J., Chan, C. C., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.019 · Cited by 101
Self-citationFrara, S., Allora, A., Castellino, L., di Filippo, L., Loli, P., & Giustina, A. (2021) · Pituitary · doi:10.1007/s11102-021-01148-1 · Cited by 101
Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
Alenquer, M., Ferreira, F., Lousa, D., Valério, M., Medina-Lopes, M., Bergman, M., Gonçalves, J., Demengeot, J., Leite, R. B., Lilue, J., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009772 · Cited by 101
Zhang, Z., Cui, F., Cao, C., Wang, Q., & Zou, Q. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.105092 · Cited by 101
Self-citationAntiviral Drug Discovery for the Treatment of COVID-19 Infections
Ng, T. I., Correia, I., Seagal, J., DeGoey, D. A., Schrimpf, M. R., Hardee, D. J., Noey, E. L., & Kati, W. M. (2022) · Viruses · doi:10.3390/v14050961 · Cited by 101
Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants
da Costa, C. H. S., de Freitas, C. A. B., Alves, C. N., & Lameira, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-12479-9 · Cited by 101
Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches
Gioia, M., Ciaccio, C., Calligari, P. A., Simone, G. D., Sbardella, D., Tundo, G. R., Fasciglione, G. F., di Masi, A., Pierro, D. D., Bocedi, A., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114225 · Cited by 100
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2
Bracken, C. J., Lim, S. A., Solomon, P. E., Rettko, N. J., Nguyen, D., Zha, B. S., Schaefer, K., Byrnes, J. R., Zhou, J., Lui, I., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-00679-1 · Cited by 100
Lenza, M. P., Oyenarte, I., Diercks, T., Quintana, J. I., Gimeno, A., Coelho, H., Diniz, A., Peccati, F., Delgado, S., Bosch, A., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202011015 · Cited by 100
Photochemical metal-free aerobic oxidation of thiols to disulfides
Spiliopoulou, N., & Kokotos, C. G. (2020) · Green Chemistry · doi:10.1039/d0gc03818k · Cited by 100
Hypertension, a Moving Target in COVID-19
Savoia, C., Volpe, M., & Kreutz, R. H. (2021) · Circulation Research · doi:10.1161/circresaha.121.318054 · Cited by 100
Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
Campione, E., Lanna, C., Cosio, T., Rosa, L., Conte, M. P., Iacovelli, F., Romeo, A., Falconi, M., Vecchio, C. D., Franchin, E., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.666600 · Cited by 100
Pascarella, S., Ciccozzi, M., Zella, D., Bianchi, M., Benedetti, F., Benvenuto, D., Broccolo, F., Cauda, R., Caruso, A., Angeletti, S., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27210 · Cited by 100
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms
Paiardi, G., Richter, S., Oreste, P., Urbinati, C., Rusnati, M., & Wade, R. C. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101507 · Cited by 100
Sehailia, M., & Chemat, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1796809 · Cited by 99
Wysocki, J. A., Ye, M., Hassler, L., Gupta, A., Wang, Y., Nicoleascu, V., Randall, G. C., Wertheim, J. A., & BATLLE, D. C. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020101537 · Cited by 99
Bayarri‐Olmos, R., Rosbjerg, A., Johnsen, L. B., Helgstrand, C., Bak-Thomsen, T. H., Garred, P., & Skjoedt, M. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100536 · Cited by 99
Jette, C. A., Cohen, A. A., Gnanapragasam, P. N. P., Muecksch, F., Lee, Y. E., Huey‐Tubman, K. E., Schmidt, F., Hatziioannou, T., Bieniasz, P. D., Nussenzweig, M. C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109760 · Cited by 99
Yang, J., Zhu, J., Sun, J., Chen, Y., Du, Y., Tan, Y., Wu, L., Zhai, M., Wei, L., Li, N., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.09.010 · Cited by 99
Low rate of daily active tobacco smoking in patients with symptomatic COVID-19Preprint
Miyara, M., Tubach, F., Pourcher, V., Morélot‐Panzini, C., Pernet, J., Haroche, J., Lebbah, S., Morawiec, É., Gorochov, G., Caumes, É., et al. (2020) · Qeios · doi:10.32388/wpp19w.4 · Cited by 99
Laps, S., Atamleh, F., Kamnesky, G., Sun, H. H., & Brik, A. (2021) · Nature Communications · doi:10.1038/s41467-021-21209-0 · Cited by 98
Bertoglio, F., Fühner, V., Ruschig, M., Heine, P. A., Abassi, L., Klünemann, T., Rand, U., Meier, D., Langreder, N., Steinke, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109433 · Cited by 98
Tian, J., Sun, J., Li, D., Wang, N., Wang, L., Zhang, C., Meng, X., Ji, X., Suchard, M. A., Zhang, X., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110969 · Cited by 98
The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus
Wells, H., Letko, M. C., Lasso, G., Ssebide, B., Nziza, J., Byarugaba, D. K., Navarrete‐Macias, I., Liang, E., Cranfield, M. R., Han, B. A., et al. (2021) · Virus Evolution · doi:10.1093/ve/veab007 · Cited by 97
Liu, J., Bodnar, B. H., Meng, F., Khan, A. I., Wang, X., Luo, G. G., Saribas, S., Wang, T., Lohani, S. C., Wang, P., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00680-8 · Cited by 97
Self-citationCurrent and Emerging Knowledge in COVID-19
Jeong, Y. J., Wi, Y. M., Park, H., Lee, J. E., Kim, S., & Lee, K. S. (2023) · Radiology · doi:10.1148/radiol.222462 · Cited by 97
Johnston, T. S., Li, S. H., Painter, M. M., Atkinson, R. K., Douek, N. R., Reeg, D. B., Douek, D. C., Wherry, E. J., & Hensley, S. E. (2024) · Immunity · doi:10.1016/j.immuni.2024.02.017 · Cited by 97
Jacobs, M., Eeckhoutte, H. P. V., Wijnant, S. R. A., Janssens, W., Joos, G., Brusselle, G., & Bracke, K. R. (2020) · European Respiratory Journal · doi:10.1183/13993003.02378-2020 · Cited by 96
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
Flanagan, K. L., Best, E., Crawford, N. W., Giles, M., Koirala, A., Macartney, K. K., Russell, F. M., Teh, B. W., & Wen, S. C.-H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.579250 · Cited by 96
A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening
Gorgulla, C., Das, K. M., Leigh, K. E., Cespugli, M., Fischer, P. D., Wang, Z., Tesseyre, G., Pandita, S., Shnapir, A., Calderaio, A., et al. (2021) · iScience · doi:10.1016/j.isci.2020.102021 · Cited by 96
Gangadevi, S., Badavath, V. N., Thakur, A., Yin, N., Jonghe, S. D., Acevedo, O., Jochmans, D., Leyssen, P., Wang, K., Neyts, J. H., et al. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c03119 · Cited by 96
Mechanisms of Antiviral Immune Evasion of SARS-CoV-2
Beyer, D. K., & Forero, A. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167265 · Cited by 96
Casciola-Rosen, L. A., Thiemann, D. R., Andrade, F., Trejo‐Zambrano, M. I., Leonard, E. K., Spangler, J. B., Skinner, N., Bailey, J. R., Yegnasubramanian, S., Wang, R., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.158362 · Cited by 96
Guo, Y., Huang, L., Zhang, G., Yao, Y., Zhou, H., Shěn, S., Shen, B., Li, B., Li, X., Zhang, Q., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22926-2 · Cited by 95
Self-citationRadvák, P., Kwon, H., Košíková, M., Ortega‐Rodriguez, U., Xiang, R., Phue, J., Shen, R., Rozzelle, J., Kapoor, N., Rabara, T. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26803-w · Cited by 95
Jamison, D. A., Narayanan, S. A., Trovão, N. S., Guarnieri, J. W., Topper, M. J., Moraes‐Vieira, P. M., Zaksas, V., Singh, K. K., Wurtele, E. S., & Beheshti, A. (2022) · European Journal of Human Genetics · doi:10.1038/s41431-022-01108-8 · Cited by 95
Martínez-Mármol, R., Giordano-Santini, R., Kaulich, E., Cho, A.-N., Przybyla, M., Riyadh, M. A., Robinson, E., Chew, K. Y., Amor, R., Meunier, F. A., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg2248 · Cited by 94
Control Measures for SARS-CoV-2: A Review on Light-Based Inactivation of Single-Stranded RNA Viruses
Hadi, J. L., Dunowska, M., Wu, S., & Brightwell, G. (2020) · Pathogens · doi:10.3390/pathogens9090737 · Cited by 94
Cardiac inflammation in COVID-19: Lessons from heart failure
Unudurthi, S. D., Luthra, P., Bose, R. J., McCarthy, J. R., & Kontaridis, M. I. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118482 · Cited by 94
Papageorgiou, A. C., & Mohsin, I. (2020) · Cells · doi:10.3390/cells9112343 · Cited by 94
Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone
Wang, C., Wang, S., Li, D., Chen, P., Han, S., Zhao, G., Chen, Y., Zhao, J., Xiong, J., Qiu, J., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00096 · Cited by 94
Deshpande, A. A., Harris, B. D., Martínez‐Sobrido, L., Kobie, J. J., & Walter, M. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691715 · Cited by 94
Baral, P., Bhattarai, N., Hossen, M. L., Stebliankin, V., Gerstman, B. S., Narasimhan, G., & Chapagain, P. P. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.08.036 · Cited by 94
Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site
Kalathiya, U., Padariya, M., Mayordomo, M. Y., Lisowska, M. M., Nicholson, J., Singh, A. J., Bagiński, M., Fåhræus, R., Carragher, N. O., Ball, K. L., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051473 · Cited by 93
Veeramachaneni, G. K., Thunuguntla, V. B. S. C., Bobbillapati, J., & Bondili, J. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1773318 · Cited by 93
Serological differentiation between COVID-19 and SARS infections
Chia, W. N., Tan, C. W., Foo, R., Kang, A. E. Z., Peng, Y., Sivalingam, V., Tiu, C. K., Ong, X. M., Zhu, F., Young, B. E., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1780951 · Cited by 93
Maria, E. D., Latini, A., Borgiani, P., & Novelli, G. (2020) · Human Genomics · doi:10.1186/s40246-020-00280-6 · Cited by 93
COVID-19 lockdown: animal life, ecosystem and atmospheric environment
Bar, H. (2020) · Environment Development and Sustainability · doi:10.1007/s10668-020-01002-7 · Cited by 93
Metadata
- Authors
- Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., & Wang, X.
- Affiliations
- Tsinghua University (CN)
- Chinese Academy of Sciences (CN)
- Corresponding author
- Zhang, Qi
- Zhang, Linqi
- Wang, Xinquan
- ORCID
- Venue
- Nature
- Published
- 2020-03-30
- Volume
- 581
- Issue
- 7807
- Pages
- 215-220
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3014067025
- Cited by
- 5,983
- References
- 38
- Citations by year
- 2026: 207 · 2025: 404 · 2024: 573 · 2023: 797 · 2022: 1237 · 2021: 1678 · 2020: 1076
- FWCI
- 152.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Salt Science Research Foundation
- Tencent
- Tsinghua University (20201080053)
- Beijing Municipal Science and Technology Commission (171100000517-001 and -003)
- Beijing Advanced Innovation Center for Structural Biology, Tsinghua University
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- SARS-CoV-2, spike protein, receptor binding domain, ACE2, crystal structure, SARS-CoV, convergent evolution, antibody epitopes, cross-reactive antibodies, viral entry, binding site residues
- MeSH terms
- Protein Domains, Betacoronavirus, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Amino Acid Sequence, Epitopes, Binding Sites, Humans, Hydrogen Bonding, Peptidyl-Dipeptidase A, Models, Molecular, Protein Binding, Receptors, Virus, Salts, Water, Sequence Alignment, Conserved Sequence, Crystallography, X-Ray, Evolution, Molecular, Severe acute respiratory syndrome-related coronavirus, Antibodies, Neutralizing, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
